Neutropenia and efficacy outcomes in patients with refractory mCRC: A post-hoc analysis of the phase III SUNLIGHT trial

被引：0

作者：

Prager, G. ^{[1
]}

Tabernero, J. ^{[2
]}

Fakih, M. ^{[3
]}

Ciardiello, F. ^{[4
]}

Van Cutsem, E. ^{[5
]}

Roby, L. ^{[6
]}

Yao, W. ^{[7
]}

Choucair, E. ^{[8
]}

Taieb, J. ^{[9
]}

机构：

[1] Univ Kliniken MedUni Wien AKH Wien, Dept Med 1, Vienna, Austria

[2] Vall dHebron Univ Hosp, Dept Med Oncol, Barcelona, Spain

[3] City Hope Comprehens Canc Ctr, Med Oncol & Therapeut Res, Duarte, CA USA

[4] Univ Campania Luigi Vanvitelli, Dipartimento Med Precis, Naples, Italy

[5] UZ Leuven Univ Hosp Leuven, Digest Oncol Dept, Campus Gasthuisberg, Leuven, Belgium

[6] IRIS, Dept Oncol, Suresnes, France

[7] Servier Pharmaceut, Dept Clin Res, Boston, MA USA

[8] Lab Servier SAS, Med Affairs, Suresnes, France

[9] Hop European George Pompidou, Gastroenterol & Digest Oncol Dept, Paris, France

来源：

ANNALS OF ONCOLOGY | 2024年 / 35卷

关键词：

D O I：

10.1016/j.annonc.2024.05.046

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

35P

引用

页码：S18 / S19

页数：2

共 50 条

[21] Impact of KRASG12 mutations on survival with trifluridine/tipiracil plus bevacizumab in patients with refractory metastatic colorectal cancer: post hoc analysis of the phase III SUNLIGHT trial [J].

Tabernero, J. ;

Taieb, J. ;

Fakih, M. ;

Prager, G. W. ;

Van Cutsem, E. ;

Ciardiello, F. ;

Mayer, R. J. ;

Amellal, N. ;

Skanji, D. ;

Calleja, E. ;

Yoshino, T. .

ESMO OPEN, 2024, 9 (03)

[22] Safety and efficacy of apixaban thromboprophylaxis in cancer patients with metastatic disease: A post-hoc analysis of the AVERT trial [J].

Knoll, William ;

Mallick, Ranjeeta ;

Wells, Philip S. ;

Carrier, Marc .

THROMBOSIS RESEARCH, 2021, 197 :13-15

[23] Lixisenatide and Renal Outcomes in Patients with Type 2 Diabetes-A Post-Hoc Analysis of the ELIXA Trial [J].

Muskiet, Marcel A. ;

Tonneijck, Lennart ;

Huang, Yao ;

Liu, Minzhi ;

Saremi, Aramesh ;

Heerspink, Hiddo Lambers. ;

Van Raalte, Daniel H. .

DIABETES, 2018, 67

[24] Switching from Eltrombopag to Hetrombopag in Patients with Primary Immune Thrombocytopenia (ITP): Post-Hoc Analysis of a Multicenter, Randomized Phase III Trial [J].

Yu Hu ;

Yang, Renchi ;

Ting Niu ;

Heng Mei ;

Liu Xiaofan ;

Yan Li ;

Hu Zhou ;

Ying Feng ;

Gao, Guangxun ;

Peng Cheng ;

Huang, Ruibin ;

Yang, Linhua ;

Hu, Jianda ;

Ming Hou ;

Yao, Yazhou ;

Li Liu ;

Yi Wang ;

Wu, De-Pei ;

Shen, Xuliang ;

Jie Jin ;

Luo, Jianmin ;

Zeng Yun ;

Xin Zhou ;

Xiang, Ruixiang ;

Jiang, Zhongxing ;

Bai, Yuansong ;

Xiong, Junye ;

Li, Runzi ;

Zou, Jianjun .

BLOOD, 2022, 140 :5543-5545

[25] Pirfenidone Delays the Prescription of Concomitant Drugs in Patients with Idiopathic Pulmonary Fibrosis: Post-Hoc Analysis of Japanese Phase III Clinical Trial [J].

Suzuki, A. ;

Sakaguchi, H. ;

Ebina, M. ;

Azuma, A. ;

Ogura, T. ;

Taguchi, Y. ;

Suga, M. ;

Takahashi, H. ;

Sugiyama, Y. ;

Kudoh, S. ;

Nukiwa, T. ;

Miyazawa, S. ;

Sakamoto, K. ;

Kondoh, Y. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201

[26] Efficacy of mirabegron in patients with and without prior antimuscarinic therapy for overactive bladder (OAB): Post-hoc analysis of a prospective, randomised European-Australian phase III trial [J].

Khullar, V ;

Cambronero, J. ;

Angulo, J. ;

Wooning, M. ;

Blauwet, M. B. ;

Dorrepaal, C. ;

Martin, N. E. .

EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) :E684-U460

[27] Efficacy of OnabotulinumtoxinA among diverse racial/ethnic groups: post-hoc analysis of the phase 4 COMPEL trial [J].

Blumenfeld, A. ;

Charleston, L. ;

Sommer, K. ;

O'Brien, H. L. .

JOURNAL OF HEADACHE AND PAIN, 2024, 25

[28] Effect of tofacitinib on dactylitis and patient-reported outcomes in patients with active psoriatic arthritis: post-hoc analysis of phase III studies [J].

Ana-Maria Orbai ;

Philip J. Mease ;

Philip S. Helliwell ;

Oliver FitzGerald ;

Dona L. Fleishaker ;

Rajiv Mundayat ;

Pamela Young .

BMC Rheumatology, 6

[29] Post Hoc Analysis of Phase III Gecacitinib Clinical Trial Outcomes: Enhanced Understanding and Implications [J].

Zhang, Yi ;

Zhou, Hu ;

Suo, Shanshan ;

Zhuang, Junling ;

Yang, Linhua ;

He, Aili ;

Liu, Qingchi ;

Du, Xin ;

Gao, Sujun ;

Li, Yarong ;

Li, Yan ;

Chen, Yuqing ;

Wu, Wen ;

Zhu, Huanling ;

He, Guangsheng ;

Hong, Mei ;

Jiang, Qian ;

Jiang, Zhongxing ;

Jing, Hongmei ;

Wang, Jishi ;

Xu, Na ;

Yue, Lingling ;

Zheng, Cuiping ;

Zhou, Zeping ;

Jin, Chenghao ;

Li, Xin ;

Liu, Lin ;

Xu, Yajing ;

Wu, Dengshu ;

Zhang, Feng ;

Zhang, Jin ;

Xiao, Zhijian ;

Jin, Jie .

BLOOD, 2024, 144 :3165-3166

[30] Effect of tofacitinib on dactylitis and patient-reported outcomes in patients with active psoriatic arthritis: post-hoc analysis of phase III studies [J].

Orbai, Ana-Maria ;

Mease, Philip J. ;

Helliwell, Philip S. ;

FitzGerald, Oliver ;

Fleishaker, Dona L. ;

Mundayat, Rajiv ;

Young, Pamela .

BMC RHEUMATOLOGY, 2022, 6 (01)

← 1 2 3 4 5 →